Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.343, 2001-01, pp. : 789-789
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Pioglitazone the answer to managing type 2 diabetes in Europe?
Inpharma, Vol. 1, Iss. 1322, 2002-01 ,pp. :
Access to resources
Recommend
Pioglitazone a star performer in the T2DM arena?
Inpharma, Vol. 1, Iss. 1607, 2007-01 ,pp. :
Paediatric rule needed in Europe?
Inpharma, Vol. 1, Iss. 1236, 2000-01 ,pp. :
Pioglitazone economically attractive for type 2 DM in Canada
Inpharma, Vol. 1, Iss. 1331, 2002-01 ,pp. :
Pioglitazone economically attractive for type 2 DM in Canada
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 356, 2002-01 ,pp. :